The Therapeutic Goods Administration (TGA) has sent a reminder that the dual labelling period for most dual labelled medicines will end on Thursday 20 April 2023. Medicine sponsors have 3 years to update labels to show only the sole medicine ingredient.
For some ingredient names dual labelling will continue for longer. These names were identified during consultation with health professionals and others who wanted more time to make sure they can keep consumers safe.
For health professionals
For some ingredient names dual labelling will continue for longer. These names were identified during consultation with health professionals and others who wanted more time to make sure they can keep consumers safe.
For health professionals
Medicines with labels using only the sole ingredient name will start to appear on shelves over time after the end of the dual labelling periods. For example, medicines containing ‘lidocaine (lignocaine)’ will begin to appear as containing ‘lidocaine’ sometime after 30 April 2023.
Take care when prescribing, dispensing, and administering medicines to make sure that the right product is selected.
Further information for health professionals: Understand ingredient names on medicine labels as they transition to show new names only.
Take care when prescribing, dispensing, and administering medicines to make sure that the right product is selected.
Further information for health professionals: Understand ingredient names on medicine labels as they transition to show new names only.